Mutant and Wild-Type RAS Cross-talk and Stoichiometric Deficiencies Are Determinants of Sensitivity to Targeted Therapies in KRASG12R Pancreatic Ductal Adenocarcinoma. - Kamgar M; Hobbes GA; Davidson R; Dorbin D; Herrera J; Langenheim JF; Burge RA; Aldakkak M; Conrardy RD; Szabo A; Thalji SZ; Mayer B; et al. (Cancer research, 2026)